<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04604808</url>
  </required_header>
  <id_info>
    <org_study_id>QoL-hPTP</org_study_id>
    <nct_id>NCT04604808</nct_id>
  </id_info>
  <brief_title>Study on the Effects of Hypoparathyroidism on Post-thyroidectomy Health-related Quality of Life (QoL-hPTP)</brief_title>
  <acronym>QoL-hPTP</acronym>
  <official_title>Observational Prospective Study on the Effects of Hypoparathyroidism on Post-thyroidectomy Health-related Quality of Life (QoL-hPTP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study will evaluate the health related quality of life (HRQoL) after a thyroidectomy and&#xD;
      the relevance of postoperative hypoparathyroidism. The patients submitted to a total&#xD;
      thyroidectomy will be evaluated with three questionaries (SF-36, Hospital HADS and a&#xD;
      specifically designed Likert-type questionary about the intensity of hypoparathyroidism&#xD;
      symptoms). The first evaluation will be before the surgery, and the other two will be&#xD;
      completed a week and a month after the procedure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients submitted to total thyroidectomy according to clinical practice will be invited to&#xD;
      participate in this study. If they accept, they will have to complete three questionaries to&#xD;
      evaluate their HRQoL: SF-36, Hospital Anxiety and Depression Scale (HADS) and a specifically&#xD;
      designed Likert-type questionary about the intensity of hypoparathyroidism symptoms; the day&#xD;
      before the surgery and one week and one month after it. In those cases that develop permanent&#xD;
      hypoparathyroidism, an additional evaluation will be done 3, 6, 9 and 12 months after&#xD;
      surgery.&#xD;
&#xD;
      Variables:&#xD;
&#xD;
        -  Demographic variables: sex, age, BMI, personal background, previous treatment.&#xD;
&#xD;
        -  Diagnosis variables: diagnosis, cytology (Bethesda System), preoperative laboratory&#xD;
           values serum (albumin, glomerular filtrate rate, total and ionic calcium, phosphate,&#xD;
           magnesium, parathormone (PTH), 25-hydroxide (OH) vitamin D, thyroid-stimulating hormone&#xD;
           (TSH), T4, thyroid antibodies).&#xD;
&#xD;
        -  Procedure variables: central compartment dissection, accidental parathyroidectomy,&#xD;
           parathyroid autotransplant, surgery length, intraoperative complications.&#xD;
&#xD;
        -  Post-operative variables:&#xD;
&#xD;
        -  Laboratory test 24h after surgery: albumin, glomerular filtrate rate, total and ionic&#xD;
           calcium, phosphate, magnesium, PTH, 25-OH vitamin D.&#xD;
&#xD;
        -  Symptoms of Hypocalcemia: presence of spontaneous symptoms of hypocalcemia, such as&#xD;
           paresthesias, and time from the surgery (measured in hours).&#xD;
&#xD;
        -  Postoperative hypocalcemia: defined by a serum albumin-corrected calcium level below 8&#xD;
           mg/dL or by the presence of hypocalcemic symptoms that require calcium or vitamin D&#xD;
           supplementation.&#xD;
&#xD;
        -  Follow-up variables: all the patients will be evaluated one week and one month after&#xD;
           surgery. When they develop a hypocalcemia, laboratory test will be repeated according to&#xD;
           clinical practice. In all cases, this test will be repeated one month after surgery,&#xD;
           together with thyroid function test. The need for oral supplementation of calcium and/or&#xD;
           vitamin D analogs or even magnesium will be collected (doses and time needed). The&#xD;
           definitive histological diagnosis and the number of additional parathyroid glands&#xD;
           identified in the surgical specimen will be also collected. In cases that developed&#xD;
           postoperative hypocalcemia, the investigators will record the time to resolution,&#xD;
           defined as the absence of calcium or vitamin D supplementation and a PTH level above 13&#xD;
           pg/mL.&#xD;
&#xD;
      Statistical Analysis:&#xD;
&#xD;
      The patients will be divided into two group depending on the development of&#xD;
      post-thyroidectomy hypoparathyroidism. The results of their HRQoL questionaries will be&#xD;
      compared within both groups. The investigators will evaluate the influence of clinical&#xD;
      variables on these results.&#xD;
&#xD;
      The quantitative variables that follow a normal distribution will be described by the mean&#xD;
      and the standard deviation; and those who do not follow the normal distribution will be&#xD;
      described by median and interquartile range. The qualitative variables will be defined by the&#xD;
      number of events and the percentage. To know if the variable follow or not the normality the&#xD;
      investigators will use de Kolmogorov-Smirnov test.&#xD;
&#xD;
      The quantitative variables with a normal distribution will be compared with Student t-test&#xD;
      (if there are two means) or with ANOVA (for more than two means). To compare quantitative&#xD;
      variables with a different distribution, the Mann-Whitney U test (2 means) or Kruskal-Wallis&#xD;
      test (more than 2) will be use.&#xD;
&#xD;
      The association between quantitative variable with a normal distribution will be stablished&#xD;
      by the Pearson correlation ratio; and for those who do not follow the normal distribution,&#xD;
      with Spearman test.&#xD;
&#xD;
      χ2 test will be used to compare qualitative variables. If an absolute frequency less or equal&#xD;
      to 5 is found in any of the contingency table cells, the Fisher's exact test will be used.&#xD;
&#xD;
      Every test will be considered if there is a minimum signification level of p&lt;0,05.&#xD;
&#xD;
      Sample size calculation:&#xD;
&#xD;
      There is not enough published data in order to help us calculate a proper sample size. the&#xD;
      investigators will conduce the first 40 patients as a pilot study, based on which it will&#xD;
      estimate a definitive sample size. The investigators will take as reference the results of&#xD;
      the SF-36 survey of the week after the surgery and a minimum difference to detect of the 10%&#xD;
      of the punctuation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in SF-36 score</measure>
    <time_frame>Preoperative, one week and one month after surgery</time_frame>
    <description>36-Item Short Form Health Survey questionnaire: 0 to 100 points, been a lower score a worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in HADS score</measure>
    <time_frame>Preoperative, one week and one month after surgery</time_frame>
    <description>Hospital Anxiety and Depression Scale: 0 to 42 points, been a higher score a worse outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes Questionary of hypocalcemia symptoms</measure>
    <time_frame>Preoperative, one week and one month after surgery</time_frame>
    <description>Specifical designed Liker-type questionary: Likert scale based score, from 1 to 10 points, been a higher score a worse outcome</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypoparathyroidism Postprocedural</condition>
  <arm_group>
    <arm_group_label>Non hypocalcemic group</arm_group_label>
    <description>Patients that don't develop post-thyroidectomy hypocalcemia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypocalcemic group</arm_group_label>
    <description>Patients that develop post-thyroidectomy hypocalcemia</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients submitted to total thyroidectomy according to clinical practice.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients submitted to total thyroidectomy&#xD;
&#xD;
          -  Patients older than 18 yo&#xD;
&#xD;
          -  Patients who accept participating in the study.&#xD;
&#xD;
          -  Patients who, before the surgery, have done a complete laboratory test.&#xD;
&#xD;
          -  Patients followed for at least one month after surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Patients submitted to a subtotal or completion thyroidectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitario de La princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Luis Muñoz de Nova, MD</last_name>
      <phone>+34915202447</phone>
      <email>jmunoz@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>José Luis Muñoz de Nova, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sofía Sánchez de Toca Gómez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia Revuelta Ramírez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Álvaro Valdés de Anca, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emma Torres Mínguez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena Martín-Pérez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 29, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</investigator_affiliation>
    <investigator_full_name>Jose Luis Muñoz de Nova</investigator_full_name>
    <investigator_title>Endocrine Surgeon Consultant</investigator_title>
  </responsible_party>
  <keyword>Health-related Quality of Life</keyword>
  <keyword>Thyroidectomy</keyword>
  <keyword>Postoperative hypoparathyroidism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoparathyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

